ASTM D5022-07

1.1 This specification deals with identification of small volume containers of drugs intended to be diluted before parenteral administration, as follows:

1.1.1 Container shape,

1.1.2 Labeling statements.

1.1.3 Vial closures and Flip-Off, type caps, and

1.1.4 Ampoule marking.

This specification deals with identification of small volume containers of drugs intended to be diluted before parenteral administration such as container shape, labeling statements, vial closures and ampoule marking. Drugs in liquid form requiring dilution before parenteral administration shall not be packaged in containers that resemble a normal syringe. The design of such containers shall preclude direct intravenous line injection of the solution. The labels on each container shall bear the words “dilute before use“. Such black metal closures and black flip-off type caps and use of a black band or series of bands above the contracture on an ampoule shall only be used for Potassium Chloride for Injection Concentrate. With this, identification of such vials and ampoules shall be easy.